+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Docosahexaenoic acid sensitizes colon cancer cells to sulindac sulfide-induced apoptosis



Docosahexaenoic acid sensitizes colon cancer cells to sulindac sulfide-induced apoptosis



Oncology Reports 27(6): 2023-2030



Sulindac analogs represent one of the most efficacious groups of NSAIDs reducing the risk of colon cancer. Recent studies have shown that sulindac sulfide, a sulindac analog effective at lower doses compared to its parent compound, triggers the death receptor (DR)5-dependent extrinsic apoptotic pathway. Induction of apoptosis via activation of the DR-mediated pathway would be an ideal therapeutic strategy to eliminate cancer cells. In this study, we investigated the possibility that colon cancer cells are sensitized to sulindac sulfide-induced apoptosis by docosahexaenoic acid (DHA), via activation of the DR/extrinsic apoptotic pathway. Our data demonstrated that DHA combination sensitized colon cancer cells to sulindac sulfide-induced apoptosis, leading to enhanced growth suppression of human colon cancer xenografts. The combination effect was primarily attributed to increased cleavage of poly(ADP-ribose) polymerase (PARP) and caspase-8 activation. Moreover, pretreatment with z-IETD-FMK (caspase-8 inhibitor) or stable expression of dominant negative caspase-8 genes blocked DHA/sulindac sulfide cotreatment-induced apoptosis. In view of the finding that DR5 silencing abrogated the combination-stimulated apoptosis, we propose that apoptotic synergy induced by sulindac sulfide plus DHA is mediated via DR5. Our findings collectively support the utility of a combination of sulindac sulfide and DHA in the effective prevention and treatment of colon cancer.

(PDF emailed within 0-6 h: $19.90)

Accession: 052683568

Download citation: RISBibTeXText

PMID: 22395735

DOI: 10.3892/or.2012.1706


Related references

Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Molecular Cancer Therapeutics 4(10): 1475-1483, 2005

Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Cancer Research 61(18): 6918-6924, 2001

Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology 117(4): 838-847, 1999

Sulindac and its metabolites sulindac sulfide and sulindac sulfone induce apoptosis in human cervical cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 39: 196, March, 1998

Sulindac sulfide induces apoptosis and modifies the expression of cyclin proteins in colon adenocarcinoma cells A potential explanation of protection against colon cancer. Journal of Investigative Medicine 46(3): 210A, March, 1998

Sulindac and sulindac sulfide reduce the level and activity of cyclin dependent kinases and induce apoptosis in HT-29 colon adenocarcinoma cells. Gastroenterology 108(4 SUPPL ): A537, 1995

Radiation protects RKO human colon carcinoma cells from apoptosis induced by sulindac sulfide. Gastroenterology 116(4 PART 2): A505, April, 1999

Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29. Experimental Cell Research 268(2): 139-149, 2001

Nutrient availability alters the effect of autophagy on sulindac sulfide-induced colon cancer cell apoptosis. Gastroenterology Research and Practice 2012: 897678-897678, 2013

Sulindac Sulfide Differentially Induces Apoptosis in Smac-Proficient and -Deficient Human Colon Cancer Cells. Molecular and Cellular Pharmacology 1(2): 92-97, 2009

Sulindac and sulindac sulfide alter the levels of Bcl-2 and Bax proteins in HT-29 colon cancer cells. Gastroenterology 108(4 SUPPL ): A475, 1995

Sulindac and sulindac sulfide alter the levels of pRb and p53 and the cyclin dependent kinase inhibitor p21 IN HT-29 colon cancer cells. Gastroenterology 108(4 SUPPL ): A475, 1995

Sulindac sulfide-induced apoptosis in sinonasal cancer cells. Acta Oto-Laryngologica 125(2): 201-206, 2005

Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis. Current Molecular Medicine 11(6): 503-511, 2012

The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene 12(4): 893-901, 1996